Current challenges and opportunities in treating glioblastoma A Shergalis, A Bankhead, U Luesakul, N Muangsin, N Neamati Pharmacological reviews 70 (3), 412-445, 2018 | 678 | 2018 |
Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury LE Gralinski, A Bankhead III, S Jeng, VD Menachery, S Proll, SE Belisle, ... MBio 4 (4), 10.1128/mbio. 00271-13, 2013 | 272 | 2013 |
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function A Sehrawat, L Gao, Y Wang, A Bankhead III, SK McWeeney, CJ King, ... Proceedings of the National Academy of Sciences 115 (18), E4179-E4188, 2018 | 199 | 2018 |
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening JW Tyner, WF Yang, A Bankhead III, G Fan, LB Fletcher, J Bryant, ... Cancer research 73 (1), 285-296, 2013 | 174 | 2013 |
Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer JT Madak, A Bankhead III, CR Cuthbertson, HD Showalter, N Neamati Pharmacology & therapeutics 195, 111-131, 2019 | 148 | 2019 |
Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells AC Sims, SC Tilton, VD Menachery, LE Gralinski, A Schäfer, MM Matzke, ... Journal of virology 87 (7), 3885-3902, 2013 | 141 | 2013 |
Role of the ERO1-PDI interaction in oxidative protein folding and disease AG Shergalis, S Hu, A Bankhead III, N Neamati Pharmacology & therapeutics 210, 107525, 2020 | 97 | 2020 |
Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus C Li, A Bankhead III, AJ Eisfeld, Y Hatta, S Jeng, JH Chang, LD Aicher, ... Journal of virology 85 (21), 10955-10967, 2011 | 88 | 2011 |
The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus JE McDermott, HD Mitchell, LE Gralinski, AJ Eisfeld, L Josset, ... BMC systems biology 10, 1-12, 2016 | 75 | 2016 |
Why all the fuss about oxidative phosphorylation (OXPHOS)? Y Xu, D Xue, A Bankhead III, N Neamati Journal of medicinal chemistry 63 (23), 14276-14307, 2020 | 73 | 2020 |
A comprehensive collection of systems biology data characterizing the host response to viral infection BD Aevermann, BE Pickett, S Kumar, EB Klem, S Agnihothram, ... Scientific data 1 (1), 1-21, 2014 | 45 | 2014 |
Menin regulates the serine biosynthetic pathway in Ewing sarcoma LK Svoboda, SSK Teh, S Sud, S Kerk, A Zebolsky, S Treichel, D Thomas, ... The Journal of pathology 245 (3), 324-336, 2018 | 44 | 2018 |
BET bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program DH Kim, D Sun, WK Storck, K Welker Leng, C Jenkins, DJ Coleman, ... Clinical Cancer Research 27 (17), 4923-4936, 2021 | 43 | 2021 |
Cellular automaton simulation examining progenitor hierarchy structure effects on mammary ductal carcinoma in situ A Bankhead III, NS Magnuson, RB Heckendorn Journal of theoretical biology 246 (3), 491-498, 2007 | 40 | 2007 |
Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes S Xu, Y Liu, K Yang, H Wang, A Shergalis, A Kyani, A Bankhead III, ... Theranostics 9 (8), 2282, 2019 | 38 | 2019 |
Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3 T Lu, A Bankhead III, M Ljungman, N Neamati Theranostics 9 (19), 5478, 2019 | 35 | 2019 |
A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight CR Cuthbertson, Z Arabzada, A Bankhead III, A Kyani, N Neamati ACS Pharmacology & Translational Science 4 (2), 624-646, 2021 | 31 | 2021 |
Rectal cancer sub-clones respond differentially to neoadjuvant therapy LM Frydrych, P Ulintz, A Bankhead, C Sifuentes, J Greenson, L Maguire, ... Neoplasia 21 (10), 1051-1062, 2019 | 29 | 2019 |
TP63 isoform expression is linked with distinct clinical outcomes in cancer A Bankhead, T McMaster, Y Wang, PS Boonstra, PL Palmbos EBioMedicine 51, 2020 | 27 | 2020 |
Molecular correlates of in vitro responses to dacomitinib and afatinib in bladder cancer S Tamura, Y Wang, B Veeneman, D Hovelson, A Bankhead III, LJ Broses, ... Bladder Cancer 4 (1), 77-90, 2018 | 22 | 2018 |